Amlod-valsa-hctz 10-320-25 MG 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FHQ5R
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $19,139
Award facts
- Contract value 100% obligated
- $19,138.67 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a $19,138.67 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the pharmaceutical product AMLOD-VALSA-HCTZ 10-320-25 MG in a 30-count supply. The contract was awarded on December 11, 2025, with an ultimate completion date of December 12, 2025, and represents a non-set-aside competitive award. This delivery order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award is issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a $999.99 billion ceiling value through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical vendor for federal medical procurement needs across military and veteran healthcare systems. The company's SPE2DX prime IDC functions as a comprehensive global pharmaceutical support vehicle enabling the supply of a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. This specific delivery order for the antihypertensive combination medication reflects AmerisourceBergen's ongoing role in fulfilling DLA's medical supply requirements for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through flexible and competitively awarded contract mechanisms.
Quick answers
Who was awarded contract SPE2DR26FHQ5R?
SPE2DR26FHQ5R was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 11, 2025.
How much is contract SPE2DR26FHQ5R worth?
The government has obligated $19,139 on SPE2DR26FHQ5R.
Is contract SPE2DR26FHQ5R an order under another contract?
Yes. SPE2DR26FHQ5R is a delivery order under SPE2DR25D1041, an indefinite delivery contract.
Was contract SPE2DR26FHQ5R competed?
The extent of competition for SPE2DR26FHQ5R was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award